Paper Details

  1. Home
  2. Paper Details

Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.

Author: OksalaH, PitkäjärviT, YlitaloP

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Glibenclamide and chlorpropamide, both oral antidiabetic drugs, were found to have similar efficacy in treating non-insulin-dependent diabetes. While glibenclamide was slightly stronger in lowering serum glucose levels, 5 mg of glibenclamide was equipotent with 250 mg of chlorpropamide. Both drugs increased serum insulin levels for more than 8 hours.
Paper Details　
Original Abstract of the Article :
The effects of single oral dose of glibenclamide (Gilemid 5 mg) and chlorpropamide (250 mg) on serum insulin and glucose levels and electrolyte (sodium, potassium) balance were studied, in a cross-over double-blind manner, in 11 patients with non-insulin-dependent diabetes. Both drugs increased seru...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3935120

データ提供：米国国立医学図書館（NLM）

Diabetes Treatment: A Desert of Choices

The world of diabetes management is a vast and complex desert, with many different treatment options available. This research focuses on the comparison of two commonly prescribed medications for type 2 diabetes: glibenclamide and chlorpropamide. The authors carefully examine the effects of these medications on blood glucose levels, insulin levels, and electrolyte balance, seeking to understand their relative effectiveness and safety.

A Comparative Study: Seeking a Pathway

The study found that both glibenclamide and chlorpropamide increased insulin levels and decreased blood glucose levels. This is like finding two different paths through the desert, each offering a different approach to managing blood sugar levels. However, the study also revealed that glibenclamide had a slightly stronger effect on insulin levels and a longer duration of action compared to chlorpropamide. This is like discovering that one path might be slightly more efficient and offer a longer-lasting impact on blood glucose control.

Navigating the Sands of Treatment

This research provides valuable insights into the comparative effectiveness of glibenclamide and chlorpropamide for type 2 diabetes. It reminds us that, just as a desert explorer must choose the right path for the journey, so too must medical professionals carefully consider the individual needs of each patient when selecting the most appropriate treatment option. The study highlights the importance of ongoing research to understand the long-term effects of these medications and the potential for individual variability in response.

Dr. Camel's Conclusion

This study offers a valuable comparative analysis of two medications for type 2 diabetes. Just as a desert traveler must carefully weigh the pros and cons of each route, so too must medical professionals choose the most effective and safe treatment for their patients. By carefully navigating the desert of diabetes management, we can help individuals achieve better blood glucose control and improve their overall health.

Date :
  1. Date Completed 1986-01-17
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3935120

DOI: Digital Object Identifier

3935120

Related Literature

Article Analysis
・Effects of chlorpropamide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.